Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programmed cell death and lipid metabolism of macrophages in NAFLD
Zhun Xiao, Minghao Liu, Fangming Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19

Showing 19 citing articles:

Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
Guido R.Y. De Meyer, Michelle Zurek, Pauline Puylaert, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 5, pp. 312-325
Closed Access | Times Cited: 43
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B. Patel
World Journal of Gastroenterology (2023) Vol. 29, Iss. 32, pp. 4831-4850
Open Access | Times Cited: 19
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
Hong-Ju Sun, Bo Jiao, Yan Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 14, pp. 1968-1981
Open Access | Times Cited: 5
Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Shuangshuang Zhao, Yan Guo, Xunzhe Yin
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 30-30
Open Access | Times Cited: 4
Novel insights into macrophage immunometabolism in nonalcoholic steatohepatitis
Yali Yuan, Ye Zhang, Xinyu Lu, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111833-111833
Closed Access | Times Cited: 4
Multicolor Two-Photon Microscopy Imaging of Lipid Droplets and Liver Capsule Macrophages In Vivo
Eun Seo Kim, Jeong-Mi Lee, Jong-Young Kwak, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 21, pp. 8467-8473
Closed Access | Times Cited: 4
Ellagic Acid Modulates Necroptosis, Autophagy, Inflammations, and Stress to Ameliorate Nonalcoholic Liver Fatty Disease in a Rat Model
Zhuoheng Li, Juan Li, Shuli He, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 1
Open Access
Pretreatment can alleviate programmed cell death in mesenchymal stem cells
Xin-xing Wan, Xi-Min Hu, Qi Zhang, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 8, pp. 773-779
Open Access | Times Cited: 1
CXCL6 promotes the progression of NAFLD through regulation of PPARα
Yanli Zou, Ting Zhan, Jiaxi Liu, et al.
Cytokine (2023) Vol. 174, pp. 156459-156459
Closed Access | Times Cited: 2
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, et al.
Frontiers in Molecular Medicine (2024) Vol. 3
Open Access
Inhibition of Hepatocellular Carcinoma by Endogenous Lipids: Induction of Pyroptosis by Geranylgeranoic Acid—A Comparison with Palmitic Acid and Retinoic Acid
Yoshihiro Shidoji
(2024)
Open Access
The new epigenetic driver role of PPARα and mitochondria in metabolic dysfunction associated liver disease (MASLD), paving the way towards new therapeutics and diagnostic biomarkers
Claudia Theys
(2024)
Open Access
Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
Gong Feng, Na He, Jing Gao, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 12, pp. 5590-5599
Closed Access
Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice
Shaohong Tao, Yu‐Qing Lei, Yimei Tan, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Association between the lymphocyte-to-high-density lipoprotein ratio and metabolic dysfunction-associated steatotic liver disease among US adults: a cross-sectional study from NHANES 2017 to 2020
Chih‐Hsin Tang, Dadi Peng, Kezhen Zong, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access
Induction of Hepatoma Cell Pyroptosis by Endogenous Lipid Geranylgeranoic Acid—A Comparison with Palmitic Acid and Retinoic Acid
Yoshihiro Shidoji
Cells (2024) Vol. 13, Iss. 10, pp. 809-809
Open Access
Identification of renal ischemia reperfusion injury subtypes and predictive model for graft loss after kidney transplantation based on programmed cell death-related genes
Jing Ji, Yuan Ma, Xintong Liu, et al.
Kidney Diseases (2024), pp. 1-18
Open Access
Macrophage-based pathogenesis and theranostics of vulnerable plaques
Fei Fang, Erxiang Wang, Min Fang, et al.
Theranostics (2024) Vol. 15, Iss. 4, pp. 1570-1588
Open Access
Foxa2 attenuates steatosis and inhibits the NF-κB/IKK signaling pathway in nonalcoholic fatty liver disease
Li Yang, Qiang Ma, Jiayu Chen, et al.
PeerJ (2023) Vol. 11, pp. e16466-e16466
Open Access
Page 1

Scroll to top